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It's estimated tha more than 1,500 Americans will d"
cancer today. And ore than 1,500 will die tomorrow. And
the next day. When 012 is over, it is estimated that 577,190
people will have been beaten by cancer.
JMU alumnu Erik Stang is working to change these dir
statistics. The 2006 JMU chemistry major is a medicinal e:liemist in the oncology discovery group at Brisrol-Myers Squibb,
a biopharmaceutical company that develops medicine to help
atients overco e serious diseases. In 1999 President Bill
Clinton awarded Bristol-Myers Squibb the National Medal of
echnology, the nation's highest recognition for technological
chievement, fon "extending and enhancing human life through
· nnovative pharmaceutical research and development."
Saving lives is not an easy task. But if anyone is up for the
challenge, it's tang. Former JMU professor (now assistant
professor of chemistry at Villanova) Kevin Minbiole worked
with Stang in his JMU organic chemistry classes. "He was
tenacious in a tough: project - one that would've sent a lesstough student running away," recalls Minbiole. "When things
go£ stuek h was highly creative as he stretched his knowledge
toward a solution."
Stang is using that creativity as a bench chemist at BristolMyers Squibb. "The purpose of my position is to synthesize
drugs that will be used to treat human cancer. I really enjoy
synthetic organic chemistry. My position allows me to build
compounds and at the same time provides me an opportunity
to make a huge impact on human health."
Stang produces compounds to be tested against cancer.
Once the biology group tests the compounds, Stang looks
over the data to see which compounds performed well and
which ones did not. Then, using these trends, he synthesizes
new compounds with refined chemical structures in hopes of
improving their performance as anti-cancer drugs.
"The job is really, really challenging," says Stang. "I not
only need to be an expert in synthetic organic chemistry to
make these drugs, but I also need to understand the biologi-
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Typically, chemists earn their Ph.D., do a post-doc fellowship or research assignment for one or two years and then
apply for jobs when they have mastered the necessary lab skills
needed for pharmaceutical chemistry. "Employers also value
creative employees who are good problem solvers, and I was
able to demonstrate that in my Ph.D. work," Stang says.
His Ph .D. work involved making new discoveries. Stang
and UIUC professor Christina White were featured in Chemical and Engineering News for their work with the Diels-Alder
reaction. The D iels-Alder reaction was first documented in
1928 and won the Nobel Prize for chemistry in 1950. It is a
very common organic chemical reaction, however, the dienes
(hydrocarbons that contain two double carbon bonds needed
to begin the reaction) are often difficult to create and are not
stable. What Stang and White did is find an effective way of
making the dienes in the reaction, so they are immediately
ready for use. The discovery has profound implications - it
saves steps and increases efficiency. Because the reaction is so
useful in making pharmaceuticals, companies can use Stang
and White's method to save time and money.
Stang describes his career success as a ladder of progression,
which started in a research lab of JMU's chemistry department. "Undergraduate research is the hallmark of JMU's
chemistry department," says Barbara Reisner, who worked
with Stang in her inorganic chemistry classes. "Students h ave
the opportunity to think of problems outside the classroom
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that require creative thinking and synthesizing different ideas."
"Students are not working on 'cookbooks ' when they're in the lab," says
Kevin Caran, JMU chemistry professor. 'They're not doing things for which
they know the outcome. They're doing
cutting-edge research, things that are
topics of interest outside of JMU."
Stang believes JMU is the perfect size
school to complete a chemistry degree,
large enough to offer modern labs and
equipment, but small enough that students are guaranteed the opportunity to
do research. "At a bigger university, it's

difficult to get into a research lab as an
undergrad . If you have 30,000 undergraduates and you're a chemistry major,
you might not be able to join a lab."
Students not only get more opportunities to do research, but more chances
to present that research at events like
JMU's Spring Undergraduate Research
Symposium. "Practicing scientific communication allows students to take ownership of their projects and be chemists,
not just chem students," says Reisner.
Because of the upper-level courses and
research opportunities in JMU 's chemistry department, Stang hit the ground
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(Above): Erik Stang ('06) is working at
Bristol-Myers Squibb to find a cure for
cancer, which affects millions.

running when he entered graduate school
and was able to launch himself into a
position at an award-winning company.
"I am in a fortunate position where my
job is to perform cutting-edge research
with the ultimate goal of curing cancer. What I love about my work is that a
good day for me could change the future
of health care."
ffi

* Learn more about the JMU chemistry
students and faculty at www.jmu.edu/
chemistry.
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